The epidemiological relevance of the COVID-19-vaccinated population is increasing/ Lancet Regional Health letter

Below is a letter compiling recent published evidence of the vaccines’ failures from multiple countries.

High COVID-19 vaccination rates were expected to reduce transmission of SARS-CoV-2 in populations by reducing the number of possible sources for transmission and thereby to reduce the burden of COVID-19 disease. Recent data, however, indicate that the epidemiological relevance of COVID-19 vaccinated individuals is increasing. In the UK it was described that secondary attack rates among household contacts exposed to fully vaccinated index cases was similar to household contacts exposed to unvaccinated index cases (25% for vaccinated vs 23% for unvaccinated). 12 of 31 infections in fully vaccinated household contacts (39%) arose from fully vaccinated epidemiologically linked index cases. Peak viral load did not differ by vaccination status or variant type[.

In Germany, the rate of symptomatic COVID-19 cases among the fully vaccinated (“breakthrough infections”) is reported weekly since 21. July 2021 and was 16.9% at that time among patients of 60 years and older [

Figure 1) providing clear evidence of the increasing relevance of the fully vaccinated as a possible source of transmission. A similar situation was described for the UK. Between week 39 and 42, a total of 100.160 COVID-19 cases were reported among citizens of 60 years or older. 89.821 occurred among the fully vaccinated (89.7%), 3.395 among the unvaccinated (3.4%)[

One week before, the COVID-19 case rate per 100.000 was higher among the subgroup of the vaccinated compared to the subgroup of the unvaccinated in all age groups of 30 years or more. In Israel a nosocomial outbreak was reported involving 16 healthcare workers, 23 exposed patients and two family members. The source was a fully vaccinated COVID-19 patient. The vaccination rate was 96.2% among all exposed individuals (151 healthcare workers and 97 patients). Fourteen fully vaccinated patients became severely ill or died, the two unvaccinated patients developed mild disease [4]


Many decisionmakers assume that the vaccinated can be excluded as a source of transmission. It appears to be grossly negligent to ignore the vaccinated population as a possible and relevant source of transmission when deciding about public health control measures.

Figure 1

Figure 1Vaccination rates and proportions of fully vaccinated people among symptomatic COVID-19 cases (≥ 60 years) in Germany between 21. July and 27. October 2021 based on the weekly reports from the Robert Koch-Institute 




Notify of
Newest Most Voted
Inline Feedbacks
View all comments
1 year ago

'Scientific paper confirms covid-19 jabs are harmful.'
The paper confirms that the vaccines mimic covid-19 infection with equal pathogenesis consequences.

Also you are immunocompromised 28 days after the jabs making you weaker than unvaccinated people.

Also confirms those who already have co-morbidities are going to be much worse off if they take the jabs (diabetics especially)

The doctors/govt have been lying that the jab is good for those with co-morbidities. It actually makes them worse off and kills them.

1 year ago

UPDATED. ‘If you get the Pfizer vax, you’re more likely to get COVID’: Industry analyst flags FDA study.

Meryl Nass, M.D.
Meryl Nass, M.D.
1 year ago

Agree that this paper shows serious problems with the vaccine that was tested. Just be aware that this was an inactivated vaccine, which is not available in the US.

1 year ago

I remember when the first safety data for the Oxford-AstraZeneca were published. The range of adverse effects (type and severity) sounded remarkably similar to the disease (COVID-19) itself. The OxAZ vaccine is a viral-vector/chimaera vaccine, built on the framework of a chimpanzee adenovirus which has been genetically modified to express the SARS-CoV-2 spike protein.

I suspect that anything with SARS-CoV-2 spike protein in it will cause a similar range of adverse effects. The only practical difference may be the dose.

I'm waiting for an intranasal COVID vaccine to be developed. That route of administration makes sense to me; intramuscular injection for a respiratory pathogen does not. Precedents: intranasal vaccines for animals, such as equine influenza, equine Strep. equi ("strangles"), and canine bordetella bronchiseptica ("kennel cough", canine infectious tracheobronchitis). Not only can it be done, it has already been done successfully, with both viral and bacterial pathogens, for years!

Catch up, humans! You might actually be able to halt transmission by eliciting a protective immune response in the upper airways using an intranasal vaccine. AND avoid all these nasty systemic effects.

Scroll to Top